{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:54:39Z","timestamp":1775804079683,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Novartis Vaccines"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.vaccine.2010.02.045","type":"journal-article","created":{"date-parts":[[2010,2,27]],"date-time":"2010-02-27T09:40:40Z","timestamp":1267263640000},"page":"3171-3179","source":"Crossref","is-referenced-by-count":78,"title":["Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines"],"prefix":"10.1016","volume":"28","author":[{"given":"A.","family":"Arguedas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Soley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Loaiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Rincon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Porras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Abdelnour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Grunwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bedell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Anemona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Dull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2010.02.045_bib1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1542\/peds.2005-1314","article-title":"Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients","volume":"116","author":"American Academy of Pediatrics Committee on Infectious Diseases (AAP)","year":"2005","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2010.02.045_bib2","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1086\/315158","article-title":"The changing epidemiology of meningococcal disease in the United States, 1992\u20131996","volume":"180","author":"Rosenstein","year":"1999","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2010.02.045_bib3","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1542\/peds.2004-2514","article-title":"Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States","volume":"115","author":"Shepard","year":"2005","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2010.02.045_bib4","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/jama.286.6.694","article-title":"Invasive meningococcal disease in adolescents and young adults","volume":"286","author":"Harrison","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2010.02.045_bib5","unstructured":"Centers for Disease Control and Prevention (CDC). Active Bacterial Core surveillance (ABCs) report emerging infections program network Neisseria meningitidis, available online at: http:\/\/www.cdc.gov\/abcs\/survreports\/mening08.pdf; 2008 [accessed January 25, 2010]."},{"issue":"2","key":"10.1016\/j.vaccine.2010.02.045_bib6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998\u20132007: implications for prevention of meningococcal disease","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2010.02.045_bib7","unstructured":"European Union Invasive Bacterial Infections Surveillance Network (EU-IBIS). Invasive Neisseria meningitidis in Europe 2006. Health Protection Agency, London, available online at: http:\/\/www.euibis.org\/documents\/2006_meningo.pdf; 2006 [accessed January 25, 2010]."},{"key":"10.1016\/j.vaccine.2010.02.045_bib8","series-title":"Vaccines","first-page":"399","article-title":"Meningococcal vaccines","author":"Granoff","year":"2008"},{"issue":"6","key":"10.1016\/j.vaccine.2010.02.045_bib9","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3201\/eid1406.071357","article-title":"Serogroup Y meningococcal disease, Colombia","volume":"14","author":"In\u00e9s Agudelo","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2010.02.045_bib10","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1128\/JCM.02390-08","article-title":"W135 invasive meningococcal strains spreading in South America: significant increase in incidence rate in Argentina","volume":"47","author":"Efron","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"01","key":"10.1016\/j.vaccine.2010.02.045_bib11","first-page":"1","article-title":"Recommended immunization schedules for persons aged 0\u201318 years \u2013 United States, 2008","volume":"57","author":"Centers for Disease Control, Prevention (CDC)","year":"2008","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2010.02.045_bib12","unstructured":"US Department of Health and Human Services. 14\u201327: Increase routine vaccination coverage levels for adolescents. In: Healthy People 2010, vol. 1. Washington, DC: US Government Printing Office, available online at: http:\/\/www.healthypeople.gov\/document\/html\/objectives\/14-27.htm; 2000 [accessed January 25, 2010]."},{"issue":"40","key":"10.1016\/j.vaccine.2010.02.045_bib13","first-page":"1100","article-title":"Vaccination coverage among adolescents aged 13\u201317 years \u2013 United States, 2007","volume":"57","author":"Centers for Disease Control, Prevention (CDC)","year":"2008","journal-title":"MMWR"},{"issue":"1","key":"10.1016\/j.vaccine.2010.02.045_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/CDLI.10.1.108-115.2003","article-title":"Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay","volume":"10","author":"Opalka","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.02.045_bib15","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.vaccine.2007.11.043","article-title":"Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6\/11\/16\/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines","volume":"26","author":"Wheeler","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.02.045_bib16","series-title":"Abstract presented at the 9th conference of the international society of travel medicine (CISTM)","article-title":"Safety and immunogenicity of quadrivalent (A, C, Y, W135) meningococcal diphtheria-polysaccharide conjugate vaccine (MCV-4): concomitant administration with tetanus-diphtheria (Td) vaccine","author":"Papa","year":"2005"},{"issue":"3","key":"10.1016\/j.vaccine.2010.02.045_bib17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1542\/peds.2005-3038","article-title":"Policy statement: prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine","volume":"117","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"2006","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2010.02.045_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0022-3476(96)70152-X","article-title":"Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants","volume":"129","author":"Schmitt","year":"1996","journal-title":"J Pediatr"},{"issue":"20","key":"10.1016\/j.vaccine.2010.02.045_bib19","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2010.02.045_bib20","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0264-410X(98)00226-6","article-title":"A search for serologic correlates of immunity to Bordetella pertussis cough illnesses","volume":"16","author":"Cherry","year":"1998","journal-title":"Vaccine"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2010.02.045_bib21","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1086\/322564","article-title":"How to make sense of pertussis immunogenicity data","volume":"33","author":"Olin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2010.02.045_bib22","series-title":"Poster presented at the 47th annual interscience conference on antimicrobial agents and chemotherapy (ICAAC)","article-title":"Immunogenicity of coadministered Tdap and MCV4 vaccines compared to separately administered vaccines","author":"Friedland","year":"2007"},{"key":"10.1016\/j.vaccine.2010.02.045_bib23","doi-asserted-by":"crossref","unstructured":"Gasparini R, Conversano M, Bona G, Gabutti G, Anemona A, Dull PM, et al. A randomised trial on the safety, tolerability, and immunogenicity of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, administered concomitantly with Tdap in adolescents and young adults. Clin Vaccine Immunol 2010 Feb 17 [Epub ahead of print].","DOI":"10.1128\/CVI.00436-09"},{"key":"10.1016\/j.vaccine.2010.02.045_bib24","unstructured":"NCT00777257. Study of Menactra\u00ae in US adolescents when administered concomitantly with Tdap vaccine, http:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00777257?term=NCT00777257&rank=1&sect=X6015&view=results#outcome1 [accessed January 25, 2010]."},{"issue":"17","key":"10.1016\/j.vaccine.2010.02.045_bib25","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1016\/j.vaccine.2006.12.047","article-title":"Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults","volume":"25","author":"McNeil","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2010.02.045_bib26","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1542\/peds.2006-0461","article-title":"Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women","volume":"118","author":"Block","year":"2006","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.vaccine.2010.02.045_bib27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1086\/521679","article-title":"Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine","volume":"196","author":"Giuliano","year":"2007","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2010.02.045_bib28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.vaccine.2008.10.088","article-title":"Immunogenicity and tolerability of an HPV-16\/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15\u201355 years","volume":"27","author":"Schwarz","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10002136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10002136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T17:54:18Z","timestamp":1590688458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10002136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":28,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0264410X10002136"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.02.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}